You have 9 free searches left this month | for more free features.

City

Charlottesville (2)

Condition

Melanoma (2)

Overall Status

Completed (1)

Terminated (1)

Sign in for free

Phase

phase 1/phase 2 (2)

Sponsor

Craig L Slingluff, Jr (2)

Collaborator

National Cancer Institute (NCI) (1)

Intervention

6mhp (2)

ipilimumab (1)

pembrolizumab (1)

Study Documents

Intervention Type

biological (2)

drug (2)

Funder Type

Other (2)

Study Type

Interventional (2)

6mhp

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Melanoma Trial in Charlottesville (6MHP, Pembrolizumab)

Completed

Melanoma

6MHP
Pembrolizumab

Charlottesville, Virginia

University of Virginia Cancer Center

Nov 15, 2020

Melanoma Trial in Charlottesville (Ipilimumab, 6MHP)

Terminated

Melanoma

Ipilimumab
6MHP

Charlottesville, Virginia

Cancer Center at the University of Virginia

Apr 21, 2020